Here are three things to know:
1. The company’s deep learning models will also use treatment and genomics datasets. Paige.ai’s initial work will center on detecting breast, prostate and other major cancers.
2. Thomas Fuchs, PhD, founded Paige.ai. Dr. Fuchs is the director of computational pathology at the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering. Dr. Fuchs said that the startup is working to develop technology to aid, not replace, pathologists.
3. Breyer Capital led the $25 million series A funding round. Paige.ai currently has five employees and plans to use some of its funding to hire at least 20 additional employees.
More articles on medical imaging:
7D Surgical finishes its greatest financing round — 4 insights
Google-owned DeepMind develops AI algorithm to diagnose optical diseases
South Florida medical imaging center mammograms may be invalid, FDA warns: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
